0000000000613220

AUTHOR

P. Brice

showing 3 related works from this author

Overall survival impact of BEACOPP versus ABVD in advanced hodgkin lymphoma: a pooled analysis of 4 randomized trials

2016

IF 6.671; International audience

[SDV.MHEP.HEM] Life Sciences [q-bio]/Human health and pathology/HematologySurvival impact[ SDV.MHEP.HEM ] Life Sciences [q-bio]/Human health and pathology/HematologyABVD[SDV.MHEP.HEM]Life Sciences [q-bio]/Human health and pathology/HematologyHodgkin lymphomaBEACOPPChimiothérapie
researchProduct

Deauville score evaluationof PET2 positive patients included in the H10 trial

2018

IF 7.704 (2017)Communication donnée lors du 31st Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Dusseldorf, Germany, du 13 au 17 octobre 2018; International audience

Nuclear Medicine & Medical Imaging[SDV.IB.IMA] Life Sciences [q-bio]/Bioengineering/Imaging[SDV.IB.IMA]Life Sciences [q-bio]/Bioengineering/Imaging[SDV.IB.MN]Life Sciences [q-bio]/Bioengineering/Nuclear medicineRadiology[SDV.IB.MN] Life Sciences [q-bio]/Bioengineering/Nuclear medicine
researchProduct

Prognosis value of baseline total metabolic tumor volume (TMTV) in advanced Hodgkin lymphoma (HL) : Ancillary study of AHL2011 LYSA trial

2016

International audience

[SDV.IB] Life Sciences [q-bio]/Bioengineering[SDV.IB.IMA] Life Sciences [q-bio]/Bioengineering/Imaging[SDV.IB.IMA]Life Sciences [q-bio]/Bioengineering/Imaging[SDV.IB]Life Sciences [q-bio]/Bioengineering[SDV.IB.MN]Life Sciences [q-bio]/Bioengineering/Nuclear medicine[ SDV.IB ] Life Sciences [q-bio]/BioengineeringComputingMilieux_MISCELLANEOUS[ SDV.IB.IMA ] Life Sciences [q-bio]/Bioengineering/Imaging[SDV.IB.MN] Life Sciences [q-bio]/Bioengineering/Nuclear medicine[ SDV.IB.MN ] Life Sciences [q-bio]/Bioengineering/Nuclear medicine
researchProduct